Biochemical and molecular characteristics of the cytochrome P450 arachidonic acid monooxygenase

Prostaglandins and Other Lipid Mediators

Volumn 62, Issue 3, 2000, Pages 271-292

  Capdevila, Jorge H ^a   Falck, John R ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Epoxygenase; Hydroxylase; Lipoxygenase; Monooxygenase

Indexed keywords

ARACHIDONIC ACID; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; PROSTANOID; STEROID 11BETA MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ENZYME ANALYSIS; ENZYME PURIFICATION; HYDROXYLATION; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; RAT; REVIEW;

ANIMALS; ARACHIDONIC ACID; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; HEMEPROTEINS; HUMANS; MIXED FUNCTION OXYGENASES; MOLECULAR CONFORMATION; NADP; OXYGENASES; RATS;

EID: 0033845886     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(00)00085-X     Document Type: Review

References (127)

1. nd ed . 1995;443 Plenum, New York.
2. Oliw E.H. Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Proc Lipid Res. 33:1994;329.
3. Harder D.R., Campbell W.B., Roman R.J. Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res. 32:1995;79.
4. Makita K., Falck J.R., Capdevila J.H. Cytochrome P450, the arachidonic acid cascade, and hypertension new vistas for an old enzyme system . FASEB J. 10:1996;1456.
5. McGiff J.C., Steinberg M., Quilley J. Missing links cytochrome P450 arachidonate products . Trends Cardiovasc Med. 6:1996;4.
6. Rahman M., Wright J.T., Douglas J.G. The role of cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function. Am J Hypertension. 10:1997;356.
7. Harder D.R., Lange A.R., Gebremedhin D., Birks E.K., Roman R.J. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res. 34:1997;237.
8. McGiff J.C., Quilley J. 20-HETE and the kidney resolution of old problems and new beginnings . Am J Physiol. 277:1999;R607.
9. Capdevila J.H., Falck J.R., Harris R.C. Cytochrome P450 and arachidonic acid bioactivation molecular and functional properties of the arachidonate monooxygenase . J Lipid Res. 41:2000;1.
10. Hasler J.A., Estabrook R.W., Murray M., et al. Human cytochromes P450. Molecular Aspects Med. 20:1999;1.
11. nd ed . 1995;419 Plenum, New York.
12. Nelson D.R., Koymans L., Kamataki T., et al. P450 superfamily update on new sequences, gene mapping, accession numbers and nomenclature . Pharmacogenetics. 6:1996;1.
13. An updated listing of P450 genes, sequences, and activities is available at http://www.dnelson@utmem1.utmem.edu.
14. nd ed . 1995;391 Plenum, New York.
15. Lund J., Zaphiropoulos P.G., Mode A., Warner M., Gustafsson J.A. Hormonal regulation of cytochrome P450 gene expression. Advances in Pharmacol. 22:1991;325.
16. Johnson E.F., Palmer C.A.N., Griffin K.J., Mei-Hui H. Role of the peroxisome-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10:1996;1241.
17. Waxman D.J. P450 gene induction by structurally diverse xenochemicals Central role of nuclear receptors CAR, PXR, and PPAR . Arch Biochem Biophys. 369:1999;11.
18. White R.E., Coon M.G. Oxygen activation by cytochrome P-450. Ann Rev Biochem. 49:1980;315.
19. nd ed . 1995;3 Plenum, New York.
20. nd ed. New York: Plenum, 1995. p. 245.
21. Smith W.L., Marnett L.J., DeWitt D.L. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther. 49:1991;153.
22. Ford-Hutchinson A.W., Gresser M., Young R.N. 5-Lipoxygenase. Annu Rev Biochem. 63:1994;383.
23. Capdevila J.H., Karara A., Waxman D.J., Martin M.V., Falck J.R., Guengerich F.P. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem. 265:1990;10865.
24. Karara A., Makita K., Jacobson H.R., et al. Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. J Biol Chem. 268:1993;13565.
25. Falck J.R., Lumin S., Blair I., et al. Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J Biol Chem. 265:1990;10244.
26. Capdevila J.H., Wei S., Helvig C., et al. The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J Biol Chem. 271:1996;22663.
27. Rahimtula A.D., O'Brien P.J. Hydroperoxide catalyzed liver microsomal aromatic hydroxylation reactions involving cytochrome P-450. Biochem Biophys Res Commun. 60:1974;440.
28. Weiss R.H., Arnold J.L., Estabrook R.W. Transformation of an arachidonic acid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450. Arch Biochem Biophys. 252:1987;334.
29. Ullrich V., Castle L., Haurand M. Cytochrome P-450 as an oxene transferase. Nozaki M., Yamamoto S., Ishimura Y., Coon M.J., Ernster L., Estabrook R.W. Oxygenases and oxygen metabolism. 1982;497 Academic, New York.
30. Song W.C., Brash A.R. Purification of an allene oxide synthase and identification of the enzyme as a cytochrome P-450. Science. 253:1991;781.
31. 2 biosynthesis. J Biol Chem. 264:1989;141.
32. Hara S., Miyata A., Yokoyama C., et al. Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. J Biol Chem. 269:1994;19897.
33. Yokoyama C., Miyata A., Ihara H., Ullrich V., Tanabe T. Molecular cloning of the human platelet thromboxane A synthase. Biochem Biophys Res Commun. 178:1991;1479.
34. Ohashi K., Ruan K.H., Kulmacz R.J., Wu K.K., Wang L.H. Primary structure of human thromboxane synthase determined from the cDNA sequence. J Biol Chem. 267:1992;789.
35. Song W.C., Funk C.D., Brash A.R. Molecular cloning of an allene oxide synthase a cytochrome P450 specialized for the metabolism of fatty acid hydroperoxides . Proc Natl Acad Sci USA. 90:1993;8519.
36. Wong P.Y.K., Malik K.U., Taylor B.M., Schneider W.P., McGiff J.C., Sun F.F. Epoxidation of prostacyclin in the rabbit kidney. J Biol Chem. 260:1985;9150.
37. 1 metabolites. Biochim Biophys Acta. 793:1984;408.
38. Zhang J.Y., Prakash C., Yamashita K., Blair I.A. Regiospecific and enantioselective metabolism of 8,9-epoxyeicosatrienoic acids by cyclooxygenase. Biochem Biophys Res Commun. 183:1992;138.
39. Jajjo H.K., Capdevila J.H., Falck J.R., Bhatt R.K., Blair I.A. Metabolism of 12(R)-hydroxyeicosatetraenoic acid by rat liver microsomes. Biochim Biophys Acta. 1123:1992;110.
40. Capdevila J, Mosset P, Yadagiri P, Sun Lumin, Falck JR. NADPH-dependent microsomal metabolism of 14,15-epoxyeicosatrienoic acid to diepoxides and epoxyalcohols. Arch Biochem Biophys 1988;261:122.
41. Hamberg M., Samuelsson B. Prostaglandins in human seminal plasma. Prostaglandins and related factors. J Biol Chem. 241:1966;257.
42. Oliw E.H. Biosynthesis of 18(R)-hydroxyeicosatetraenoic acid from arachidonic acid by microsomes of monkey seminal vesicles. J Biol Chem. 264:1989;17845.
43. 1. Eur J Biochem. 11:1969;390.
44. Kupfer D. Endogenous substrates of monooxygenases fatty acids and prostaglandins . Schenkman J.B., Kupfer D. Hepatic cytochrome P-450 monooxygenase system. 1982;157 Pergamon, New York.
45. Kupfer D., Jansson I., Favreau L.V., Theoharides A.D., Schenkman J.B. Regioselective hydroxylation of prostaglandins by constitutive forms of cytochrome P-450 from rat liver formation of a novel metabolite by a female-specific P-450 . Arch Biochem Biophys. 262:1988;186.
46. p-2). J Biol Chem. 62:1987;13366.
47. Sharma R.K., Doig M.V., Lewis D.F.V., Gibson G. Role of hepatic and renal cytochrome P450 IVA1 in the metabolism of lipid substrates. Biochem Pharmacol. 38:1989;3621.
48. Yokotani N., Bernhardt R., Sogawa K., et al. Two forms of ω-hydroxylase toward prostaglandin A and laurate. cDNA cloning and their expression. J Biol Chem. 264:1989;21665.
49. Roman L.J., Palmer C.N.A., Clark J.E., et al. Expression of rabbit cytochrome P4504A which catalyzes the ω-hydroxylation of fatty acids, and prostaglandins. Arch Biochem Biophys. 307:1993;57.
50. Kimura S., Hardwick J.P., Kozac C.A., Gonzalez F.J. The rat clofibrate inducible CYP4A subfamily II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinated and tissue specific regulation of the CYP4A genes. DNA. 8:1989;517.
51. Imaoka S., Tanaka S., Funae Y. ω and (ω-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450. Biochem Int. 18:1989;731.
52. Kimura S., Hanioka N., Matsunaga E., Gonzalez F.J. The rat clofibrate-inducible CYP4A gene subfamily I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization and identification of a conserved 19-bp upstream element. DNA. 8:1989;503.
53. Imaoka S., Nagashima K., Funae Y. Characterization of three cytochrome P450s purified from renal microsomes of untreated male rats and comparison with human renal cytochrome P450. Arch Biochem Biophys. 276:1990;473.
54. Stromsteadt M., Hayashi S., Zaphiropoulos P.G., Gustafsson J.A. Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate. DNA Cell Biol. 8:1990;569.
55. Johnson E.F., Walker D.L., Griffin K.J. Cloning and expression of three rabbit kidney cDNAs encoding lauric acid-hydroxylases. Biochemistry. 29:1990;873.
56. kd which shows a fatty acid ω-hydroxylating activity. Eur J Biochem. 196:1991;531.
57. 2-terminal amino acid sequences of human and rat kidney fatty acid ω-hydroxylases. Biochem Biophys Acta. 1123:1992;156.
58. Sawamura A., Kusunose E., Satouchi K., Kusunose M. Catalytic properties of rabbit kidney fatty acid ω-hydroxylase cytochrome P-450ka2 (CYP4A7). Biochim Biophys Acta. 1168:1993;30.
59. Palmer C.N.A., Richardson J.H., Griffin K.J., et al. Characterization of a cDNA encoding a human kidney cytochrome P-450 4A fatty acid ω-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim Biophys Acta. 1172:1993;61.
60. Imaoka S., Ogawa H., Kimura S., Gonzalez F.J. Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid ω-hydroxylase expressed in human kidney. DNA Cell Biol. 12:1993;893.
61. Wang M.H., Stec D.E., Balazy M., et al. Cloning, sequencing, and cDNA-directed expression of rat renal CYP4A2 arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein . Arch Biochem Biophys. 336:1997;240.
62. Helvig C., Dishman E., Capdevila J.H. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3. Biochemistry. 37:1998;12546.
63. Nguyen X., Wang M.-H., Reddy K.M., Falck J.R., Schwartzman M.L. Kinetic profile of the rat CYP4A isoforms Arachidonic acid metabolism and isoform specific inhibitors . Am J Physiol. 276:1999;R1691.
64. Jubiz W., Radmark O., Malmsten C., et al. A novel leukotriene produced by stimulation of leukocytes with formylmethionylleucylphenylalanine. J Biol Chem. 257:1981;6106.
65. 4 20-hydroxylase from polymorphonuclear leukocytes. J Biol Chem. 259:1984;3082.
66. 4 in human polymorphonuclear leukocytes. J Biol Chem. 259:1984;10181.
67. 4 hydroxylases. J Biol Chem. 262:1987;1590.
68. 4 20-hydroxylase. J Biol Chem. 262:1987;12421.
69. Sumimoto J., Takeshige K., Minakami S. Characterization of human neutrophil leukotriene B4 omega-hydroxylase, a system involving a unique cytochrome P-450 and NADPH-cytochrome P-450 reductase. Eur J Biochem. 172:1988;315.
70. Kikuta Y., Kusunose E., Endo K., et al. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. J Biol Chem. 268:1993;9376.
71. Kikuta Y., Kusunose E., Kusunose M. Purification and characterization of recombinant rat hepatic CYP4F1. Arch Biochem Biophys. 369:1999;193.
72. 4 omega-hydroxylase. J Biol Chem. 274:1999;21191.
73. Wong P.Y.K., Westlund P., Hamberg M., Granstrom E., Chao P.W.H., Samuelsson B. ω-Hydroxylation of 12 liters-hydroxy-5,8,10,14-eicosatetraenoic acid in human polymorphonuclear leukocytes. J Biol Chem. 259:1984;2683.
74. Marcus A.J., Safier L.B., Ullman H.L., et al. 12S,20-Dihydroxyeicosatetraenoic acid a new icosanoid synthesized by neutrophils from 12S-hydroxyeicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets . Proc Natl Acad Sci USA. 81:1984;903.
75. 2+ and protein kinase C mobilization in neutrophils. Biochem Biophys Res Commun. 148:1987;575.
76. Okita R.T., Soberman R.J., Bergholte J.M., Masters B.S.S., Hayes R., Murphy R.C. ω-Hydroxylation of 15-hydroxyeicosatetraenoic acid by lung microsomes from pregnant rabbits. Mol Pharmacol. 32:1987;706.
77. 4 and of their all-trans isomers by human leukocytes and rat liver microsomes. Biochem Biophys Res Commun. 177:1991;134.
78. 4 ω-hydroxylase (cytochrome P-450LTB omega) . Biochim Biophys Acta. 1168:1993;87.
79. Zeldin D.C., Kobayashi J., Falck J.R., et al. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem. 268:1993;640.
80. Masters B.S., Okita R.T., Muerhoff A.S., et al. Pulmonary P-450-mediated eicosanoid metabolism and regulation in the pregnant rabbit. Adv Prostagland Thrombox Leukotr Res. 19:1989;335.
81. Sharma R.K., Lake B.G., Makowski R., et al. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Eur J Biochem. 184:1989;69.
82. Orellana M., Valdes E., Capdevila J.H., Gil L. Nutritionally triggered alterations in the regiospecificity of arachidonic acid oxygenation by rat liver microsomal cytochrome P450. Arch Biochem Biophys. 274:1989;251.
83. Kroetz D.L., Yook P., Costet P., Bianchi P., Pineau T. Peroxisome proliferator-activated receptor alpha controls hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem. 273:1998;31581.
84. Capdevila J.H., Wei S., Yan Y., et al. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem. 267:1992;21720.
85. Oliw E.H. bis-Allylic hydroxylation of linoleic acid and arachidonic acid by human hepatic 7 monooxygenases. Biochim Biophys Acta. 1166:1993;258.
86. Brash A.R., Boeglin W.E., Capdevila J.H., Yeola S., Blair I.A. 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent arachidonic acid metabolism in rat liver microsomes analysis of their stereochemistry, and the stereochemistry of their acid-catalyzed rearrangement . Arch Biochem Biophys. 321:1995;485.
87. Capdevila J.H., Yadagiri P., Manna S., Falck J.R. Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. Biochem Biophys Res Commun. 141:1986;1007.
88. Woollard P.M. Stereochemical differences between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochem Biophys Res Commun. 136:1986;169.
89. +-ATPase in the cornea . Proc Natl Acad Sci USA. 84:1987;8125.
90. Boeglin W.E., Kim R.B., Brash A.R. A 12R-lipoxygenase in human skin mechanistic evidence, molecular cloning, and expression . Proc Natl Acad Sci USA. 95:1998;6744.
91. Sun D., McDonnel M., Chen X.S., et al. Human 12(R)-lipoxygenase and the mouse ortholog. Molecular cloning, expression, and gene chromosomal assignment. J Biol Chem. 273:1998;33540.
92. Murphy R.C., Falck J.R., Lumin S., et al. 12(R)-Hydroxyeicosatrienoic acid a vasodilator cytochrome P-450-dependent arachidonate metabolite from bovine corneal epithelium . J Biol Chem. 263:1988;17197.
93. Oliw EH. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by bovine corneal epithelium. Acta Physiol Scand 1993;1993:147:117.
94. Aldridge T.C., Tugwood J.D., Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem J. 306:1995;473.
95. Simpson A.E., Brammar W.J., Pratten M.K., Elcombe C.R. Translactational induction of CYP4A expression in 10.5-day neonatal rats by the hypolipidemic drug clofibrate. Biochem Pharmacol. 50:1995;2021.
96. Sundseth S.S., Waxman D.J. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid ω-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J Biol Chem. 267:1992;3915.
97. Hashimoto T., Fujita T., Usuda N., et al. Peroxisomal and mitochondrial fatty acid oxidation in mice nullizygous for both peroxisomal proliferator activated receptor and peroxisomal fatty acyl-CoA oxidase. J Biol Chem. 274:1999;19228.
98. Heng Y.M., Kuo S., Jones P.S., et al. A novel murine gene, Cyp4a14, is part of a cluster of Cyp4a and 4b, but not Cyp4F genes in mouse and humans. Biochem J. 325:1997;741.
99. Rifkind A.B., Kanetoshi A., Orlinick J., Capdevila J.H., Lee C. Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J Biol Chem. 269:1994;3387.
100. Laethem R.M., Balazy M., Falck J.R., Laethem C.L., Koop D.R. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome 450 2E1. J Biol Chem. 268:1993;12912.
101. Karara A., Dishman E., Blair I., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J Biol Chem. 264:1989;19822.
102. Karara A., Dishman E., Jacobson H., Falck J.R., Capdevila J.H. Arachidonic acid epoxygenase. Stereochemical analysis of the endogenous epoxyeicosatrienoic acids of human kidney cortex. FEBS Lett. 268:1990;227.
103. Falck J.R., Schueler V.J., Jacobson H.R., Siddhanta A.K., Pramanik B., Capdevila J. Arachidonate epoxygenase identification of epoxyeicosatrienoic acids (EETs) in rabbit kidney . J Lipid Res. 28:1987;840.
104. Karara A., Wei S., Spady D., Swift L., Capdevila J.H., Falck J.R. Arachidonic acid epoxygenase structural characterization and quantification of epoxyeicosatrienoates in plasma . Biochem Biophys Res Commun. 182:1992;1320.
105. Zeldin D.C., DuBois R.N., Falck J.R., Capdevila J.H. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochem Biophys. 322:1995;76.
106. Daikh B.E., Laethem R.M., Koop D. Stereoselective epoxidation of arachidonic acid by cytochrome P-450s 2CAA and 2C2. J Pharmacol Expt Ther. 269:1994;1130.
107. Keeney D.S., Skinner C., Wei S., Friedberg T., Waterman M.R. A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J Biol Chem. 273:1998;9279.
108. Knickle L.C., Bend J.R. Bioactivation of arachidonic acid by the cytochrome P450 monooxygense of guinea pig lung the orthologue of cytochrome P450 2B4 is solely responsible for the formation of epoxyeicosatrienoic acids . Mol Pharmacol. 45:1994;1273.
109. Keeney D.S., Skinner C., Travers J.B., et al. Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J Biol Chem. 273:1998;32071.
110. Holla V.R., Makita K., Zaphiropoulos P.G., Capdevila J.H. The kidney cytochrome P450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest. 104:1999;751.
111. Imaoka S., Zwedlung P.J., Ogawa H., Kimura S., Gonzalez F.J., Kim H.Y. Identification of CYP2C23 expressed in rat kidney an an arachidonic acid epoxygenase. J Pharamcol Exp Ther. 267:1993;1012.
112. Wu S., Moomaw C.R., Tomer K.B., Falck J.R., Zeldin D.C. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem. 271:1996;3460.
113. Laethem R.M., Halpert J.R., Koop D.R. Epoxidation of arachidonic acid as an active site probe of cytochrome P450 2B isoforms. Biochim Biophys Acta. 1206:1994;42.
114. Zeldin D.C., Foley J., Boyle J.E., et al. Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology. 138:1997;1338.
115. Luo G., Zeldin D.C., Blaisdell J.A., Hodgson E., Goldstein J.A. Cloning, and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys. 357:1998;45.
116. Zeldin D.C., Moomaw C.R., Jesse N., et al. Biochemical characterization of the human liver cytochrome P450 arachidonic acid pathway. Arch Biochem Biophys. 330:1996;87.
117. Graham-Lorence S., Truan G., Peterson J.A., et al. An active site substitution, F87V, converts cytochrome P450 BM3 into a regio- and stereoselective (14)S,15(R)-arachidonic acid epoxygenase. J Biol Chem. 272:1997;1127.
118. Rifkind A.B., Lee C., Chang T.K., Waxman D.J. Arachidonic acid metabolisms by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2 regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes . Arch Biochem Biophys. 320:1995;380.
119. Ma J., Qu W., Scarborough P.E., et al. Molecular cloning, enzymatic characterization, developmental expresion, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J Biol Chem. 274:1999;17777.
120. Fisslthaler B., Popp R., Kiss L., et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 410:1999;493.
121. Karara A., Dishman E., Falck J.R., Capdevila J.H. Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J Biol Chem. 266:1991;7561.
122. Brezinski M., Serhan C.N. Selective incorporation of 15(S)-hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils agonist-induced deacylation and transformation of stored hydroxyeicosanoids . Proc Natl Acad Sci USA. 87:1990;6248.
123. Legrand A.B., Lawson J.A., Meyrick B.O., Blair I.A., Oates J.A. Substitution of 15-hydroxyeicosatetraenoic acid in the phosphoinositide signaling pathway. J Biol Chem. 266:1991;7570.
124. Bernstrom K., Kayganich K., Murphy R.C., Fitzpatrick F.A. Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J Biol Chem. 267:1992;3686.
125. Capdevila J.H., Jin Y., Karara A., Falck J.R. Cytochrome P450 epoxygenase dependent formation of novel endogenous epoxyeicosatrienoyl-phospholipids. Nigam S., Marnett L.J., Honn K.V., Walden T.L. Jr. Eicosanoids and other bioactive lipids in cancer, inflamation and radiation injury. 1993;11 Kluwer Academic, Boston, MA.
126. Chen J, Capdevila JH, Zeldin DC, Rosenberg RL. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids. Mol Pharmacol 199;55:288.
127. Nebert D.W., Gonzalez F.J. P450 Genes structure, evolution, and regulation . Annu Rev Biochem. 56:1987;945.